IMRN 6-K SEC Filing Analysis

Latest settled — T+5d

IMRN ▲ +12.81% at T+5d

NEUTRAL call ✓ call won +12.81% · α vs SPY +12.86% · entry $1.21 → $1.37

Next anchor: T+20d in 11d

Last close $1.19 (close Jun 12) · -1.65% from $1.21 entry

Entry anchored
May 28, 07:06 AM ET
via Databento tick

T+1d

+19.83%

call +19.83% · α +19.59%

$1.45

settled 17d ago

T+5d

+12.81%

call +12.81% · α +12.86%

$1.37

settled 11d ago

T+20d

—

call — · α —

—

in 11d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Immuron filed a 6-K containing its response to an ASX price query regarding a sharp price spike from A$0.032 to A$0.044 on May 27-28, 2026. The company stated it is not aware of any undisclosed material information and attributed the trading activity to a CEO presentation at the Emerging Growth Conference on May 8, 2026. The filing is a routine regulatory response with no new material financial or operational information.

Actionable Insight

No new material information was disclosed. The price spike appears driven by retail interest following a May 8 CEO presentation. Monitor for any subsequent operational updates or clinical catalysts that could sustain momentum.

Key Facts

ASX queried a price move from A$0.032 to A$0.044 and a significant volume increase on May 27-28, 2026.
Immuron stated it is not aware of any undisclosed information that would explain the trading.
The company attributed the trading to a CEO presentation at the Emerging Growth Conference on May 8, 2026, previously disclosed.
Immuron confirmed compliance with ASX Listing Rule 3.1 (continuous disclosure).
The response was authorized by the Board of Directors.

Financial Impact

No financial figures reported; filing is a regulatory response with no new financial data.

Risk Factors

No material news to support the recent price increase — risk of mean reversion.
Micro-cap with $8M market cap is susceptible to volatile price swings on low volume.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
6-K Filing (Primary)	0001213900-26-061760
Document: ea0292481-6k_immuron.htm	0001213900-26-061760
Document: 0001213900-26-061760-index-headers.html	0001213900-26-061760
Document: 0001213900-26-061760-index.html	0001213900-26-061760
Document: 0001213900-26-061760.txt	0001213900-26-061760

5 reports for IMRN

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for IMRN — sortable, filterable
	Type				Now
May 28, 2026 17d ago	6-K NEUTRAL ★ 3/10	$1.21 $1.37	▲ +12.81%	▲ +12.86%	$1.19 (−1.65%)
May 8, 2026 5w ago	6-K NEUTRAL ★ 4/10	$0.8050 $1.11	▲ +37.89%	▲ +36.42%	$1.19 (+47.83%)
Apr 17, 2026 8w ago	Press Release BULLISH ★ 6/10	$0.9580 $0.8940	▼ −6.68%	▼ −7.24%	$1.19 (+24.22%)
Apr 17, 2026 8w ago	6-K BULLISH ★ 6/10	$0.9580 $0.8940	▼ −6.68%	▼ −7.24%	$1.19 (+24.22%)
Apr 13, 2026 8w ago	6-K NEUTRAL ★ 3/10	$0.7860 $0.9580	▲ +21.88%	▲ +18.59%	$1.19 (+51.40%)

US Market Status

Market Closed — Opens in 2h 55m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access